SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
GALT

Galectin Therapeutics Inc (NASDAQ:GALT)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
3.19-0.19 (-5.62%)
 
Market cap
$210M
Analyst consensus
Insider Score
––Not scored
GALT Insider Score

Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

GALT Stock Insider Trading Activity

GALT stock’s insider trading shows 8 sales on the open market for an estimated $521.75K by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Uihlein Richard E
Director
Option exercise31,825,235$3.00$95.48M 308%42,162,911Jul 31, 2026— Form 4
Uihlein Richard E
Director
Option exercise2,550,932$4.05$10.33M 6.1%44,713,843Jul 31, 2026— Form 4
Jamil Khurram
Other
Sell16,250$5.13$83.28K 100%0Jul 14, 2026— Form 4
Jamil Khurram
Other
Option exercise16,250$3.04$49.40K New16,250Jul 14, 2026— Form 4
Shlevin Harold H.
Director
Option exercise22,268$1.23$27.39K 343%28,768Jun 29, 2026— Form 4
Jamil Khurram
Other
Sell47,467$5.04$239.23K 100%0Jun 29, 2026— Form 4
Jamil Khurram
Other
Option exercise47,467$2.50$118.67K New47,467Jun 29, 2026— Form 4
Shlevin Harold H.
Director
Sell22,268$5.04$112.23K 77.4%6,500Jun 29, 2026— Form 4
Jamil Khurram
Other
Option exercise2,037$2.20$4.48K New2,037Jun 26, 2026— Form 4
Shlevin Harold H.
Director
Sell7,732$5.00$38.66K 54.3%6,500Jun 26, 2026— Form 4
Shlevin Harold H.
Director
Option exercise7,732$1.23$9.51K 119%14,232Jun 26, 2026— Form 4
Jamil Khurram
Other
Option exercise2,533$2.50$6.33K New2,533Jun 26, 2026— Form 4
Jamil Khurram
Other
Sell2,533$5.00$12.66K 100%0Jun 26, 2026— Form 4
Jamil Khurram
Other
Sell2,037$5.00$10.19K 100%0Jun 26, 2026— Form 4
Jamil Khurram
Other
Sell7,557$3.14$23.73K 100%0Jun 23, 2026— Form 4
Jamil Khurram
Other
Option exercise7,557$1.23$9.30K New7,557Jun 23, 2026— Form 4
Jamil Khurram
Other
Sell568$3.10$1.76K 100%0May 26, 2026— Form 4
Jamil Khurram
Other
Option exercise568$1.23$698.64 New568May 26, 2026— Form 4
ELDRED KARY
Director
Buy300$2.70$810 0.5%65,682Feb 6, 2026D Form 4
Uihlein Richard E
Director
Award13,158$3.04$40.00K 0.1%10,332,676Jan 16, 2026— Form 4
Jamil Khurram
Other
Sell21,446$3.65$78.28K 100%0Jan 6, 2026— Form 4
LEWIS JOEL
CEO
Sell37,698$3.58$134.96K 4.3%832,592Jan 6, 2026— Form 4
CALLICUTT JACK W
CFO
Sell20,354$3.67$74.70K 72.8%7,614Jan 6, 2026— Form 4
CALLICUTT JACK W
CFO
Sell25,732$3.90$100.35K 47.9%27,968Jan 5, 2026— Form 4
Jamil Khurram
Other
Sell25,499$3.90$99.45K 54.3%21,446Jan 5, 2026— Form 4
LEWIS JOEL
CEO
Sell27,731$3.91$108.43K 3.1%870,290Jan 5, 2026— Form 4
LEWIS JOEL
CEO
Buy56,332$3.88$218.57K 6.8%776,260Jan 5, 2026— Form 4
LEWIS JOEL
CEO
Sell18,571$4.20$78.00K 2.0%898,021Jan 2, 2026— Form 4
CALLICUTT JACK W
CFO
Sell13,914$4.20$58.44K 20.6%53,700Jan 2, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Buy (P) — Open-market or private purchase
  • Sell (S) — Open-market or private sale
  • Award (A) — Grant or award from the company, not a purchase
  • Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.